AptamiR Therapeutics, Inc. — Form D
AptamiR Therapeutics, Inc. of Austin, TX, a company, filed a Form D exempt-offering notice with the SEC on 2015-09-18. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-09-18
- Form: D
- Accession: 0001653483-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $3.0M
- Minimum investment: $3.0M
- Investors: 1
- Date of first sale: 2015-09-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-247904
Issuer
- Name: AptamiR Therapeutics, Inc.
- CIK: 0001653483
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: c/o The Austin Technology Incubator, Austin, TX, 78759
- Phone: 239-682-3791
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Philippe Camus | Director | Austin, TX |
| Marc Thibonnier | Director | Austin, TX |
| Philippe Camus | Executive Officer | Austin, TX |
| Marc Thibonnier | Executive Officer | Austin, TX |
More